Variants in BRCA1 and BRCA2 account for a plurality of hereditary breast and ovarian cancer (HBOC) cases, and are associated with risks of 50–85% for breast cancer and 15–40% for ovarian cancer [1–4]. Here, BRCA1 is linked to ovarian carcinoma.